Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells-Reference-Cited by-同舟云学术

Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells

Published:2015-07-08 Issue:16 Volume:172 Page:4189-4199
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Shayhidin Elnur Elyar¹,Forcellini Elsa²,Boulanger Marie-Chloé¹,Mahmut Ablajan¹,Dautrey Sébastien²,Barbeau Xavier³,Lagüe Patrick³,Sévigny Jean⁴⁵,Paquin Jean-François²,Mathieu Patrick¹

Affiliation:

1. Laboratoire d'Études Moléculaires des Valvulopathies (LEMV); Groupe de Recherche en Valvulopathies (GRV); Quebec Heart and Lung Institute/Research Center; Department of Surgery; Université Laval; QC Canada

2. Canada Research Chair in Organic and Medicinal Chemistry; PROTEO; Department of Chemistry; Université Laval; QC Canada

3. Department of Biochemistry; PROTEO; Laval University; QC Canada

4. Department of Microbiology; Infectious Diseases and Immunology; Université Laval; Québec QC Canada

5. Centre de recherche du CHU de Québec; Québec QC Canada

Funder

Heart and Stroke Foundation of Canada (HSFC)

Canadian Institutes of Health Research (CIHR)

Fonds de recherche du Québec - Nature et technologies (FRQNT)

Fonds de recherche du Québec - Santé (FRQS)

The Canada Research Chair Program

Natural Sciences and Engineering Research Council of Canada

Canada Foundation for Innovation